Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001410578-25-000576
Filing Date
2025-03-31
Accepted
2025-03-31 16:05:36
Documents
61
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K tdac-20241231x10k.htm   iXBRL 10-K 1130213
2 EX-4.5 tdac-20241231xex4d5.htm EX-4.5 31129
3 EX-19 tdac-20241231xex19.htm EX-19 40247
4 EX-21 tdac-20241231xex21.htm EX-21 970
5 EX-31.1 tdac-20241231xex31d1.htm EX-31.1 13385
6 EX-31.2 tdac-20241231xex31d2.htm EX-31.2 14009
7 EX-32.1 tdac-20241231xex32d1.htm EX-32.1 6743
8 EX-32.2 tdac-20241231xex32d2.htm EX-32.2 5912
9 EX-97 tdac-20241231xex97.htm EX-97 25602
  Complete submission text file 0001410578-25-000576.txt   5106470

Data Files

Seq Description Document Type Size
10 EX-101.SCH tdac-20241231.xsd EX-101.SCH 44567
11 EX-101.CAL tdac-20241231_cal.xml EX-101.CAL 20803
12 EX-101.DEF tdac-20241231_def.xml EX-101.DEF 183205
13 EX-101.LAB tdac-20241231_lab.xml EX-101.LAB 330725
14 EX-101.PRE tdac-20241231_pre.xml EX-101.PRE 273237
64 EXTRACTED XBRL INSTANCE DOCUMENT tdac-20241231x10k_htm.xml XML 619182
Mailing Address 52 E 83RD ST. NEW YORK NY 10028
Business Address 52 E 83RD ST. NEW YORK NY 10028 (413) 204-2769
Translational Development Acquisition Corp. (Filer) CIK: 0001926599 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-42451 | Film No.: 25793155
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)